Loading…

U-Shape Relationship between Plasma Leucine Level and Mortality in the Intensive Care Unit

Patients in the intensive care unit (ICU) are at high risk of mortality which is not well predicted. Previous studies noted that leucine has prognostic value in a variety of diseases. This study investigated whether leucine concentration was a useful biomarker of metabolic and nutritional status and...

Full description

Saved in:
Bibliographic Details
Published in:Disease markers 2022, Vol.2022, p.7389258-9
Main Authors: Wang, Mei-Ying, Wang, Chao-Hung, Chen, Wei-Siang, Chu, Chien-Ming, Wu, Huang-Ping, Liu, Min-Hui, Lin, Yi-Tsen, Kao, Kuo-Chin, Liang, Chung-Yu, Chen, Wen-Hsin, Wang, Huei-Jen, Lee, Shu-Chiu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients in the intensive care unit (ICU) are at high risk of mortality which is not well predicted. Previous studies noted that leucine has prognostic value in a variety of diseases. This study investigated whether leucine concentration was a useful biomarker of metabolic and nutritional status and 6-month mortality in ICU. We recruited 454 subjects admitted to ICU (348 and 106 in the initiation and validation cohorts, respectively) with an acute physiology and chronic health evaluation (APACHE II) score≥15. We measured plasma leucine concentrations, traditional biomarkers, and calculated APACHE II and sequential organ failure assessment (SOFA) scores. Leucine levels were weakly correlated with albumin, prealbumin, and transferrin levels (r=0.30, 0.12, and 0.15, p=0.001, 0.029, and 0.007, respectively). During follow-up, 116 (33.3%) patients died. Compared to patients with leucine levels between 109 and 174 μM, patients with leucine>174 μM or 174 μM had higher alanine aminotransferase levels, but no significant differences in other variables; patients with leucine levels174 μM was an independent predictor of mortality, especially early mortality. However, among patients who stayed in ICU longer than two weeks, leucine
ISSN:0278-0240
1875-8630
DOI:10.1155/2022/7389258